Clinical Trials for Lumos Pharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Lumos Pharma

Clinical Trials (4)

NCT07129759
Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency
PHASE3Not yet recruiting
150 participants
Started: Sep 30, 2026 · Completed: Feb 28, 2030
1 condition1 sponsor0 locations
NCT06948214
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
PHASE3Recruiting
150 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT05796440
A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)
PHASE2Enrolling by invitation
60 participants
Started: Aug 1, 2023 · Completed: Apr 30, 2028
1 condition1 sponsor7 locations
NCT04806854
PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212)
PHASE2Active, not recruiting
24 participants
Started: Jul 14, 2021 · Completed: Jul 31, 2030
1 condition1 sponsor1 location